Literature DB >> 33380215

Natural products from Vitex polygama and their antimycobacterial and anti-inflammatory activity.

Cristiane Catela Martins de Jesus1,2, Marlon Heggdorne de Araújo1,2, Thatiana Lopes Biá Ventura Simão2,3, Elena B Lasunskaia3, Thiago Barth1,2, Michelle Frazão Muzitano1,2, Shaft Corrêa Pinto2.   

Abstract

Tuberculosis (TB) remains a worldwide public health threat because of the emergence of resistant strains and subsequent inappropriate response to current therapy. We have been studying the restinga plants' antimycobacterial and anti-inflammatory potential. Dichloromethane fraction (DCM) from Vitex polygama Cham. showed high activity against Mycobacterium tuberculosis (Mtb) H37Rv. In this context, DCM fraction and isolated compounds were investigated against Mtb H37Rv and M299 (MDR strain) and for their immunomodulatory and cytotoxicity actions. Orientin showed the best antimycobacterial effect against Mtb M299 MDR strain (MIC50 15.4 ± 1.6 µg/mL), capacity of inhibiting NO production by macrophages (IC50 6.5 ± 1.2 µg/mL) and no significant cytotoxicity. The antimycobacterial effect of orientin was also observed on Mtb H37Rv intracellular growth in RAW 264.7 macrophages (MIC50 3.5 ± 1.1 and MIC90 9.1 ± 1.0 µg/mL). This is the first report describing the antimycobacterial effect of orientin, in both extra- and intracellular growth.[Formula: see text].

Entities:  

Keywords:  20-hydroxyecdysone; Vitex polygama; anti-inflammatory; isoorientin; orientin; tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 33380215     DOI: 10.1080/14786419.2020.1868461

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  1 in total

Review 1.  Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models.

Authors:  Hongkui Chen; Min Zheng; Wenhui Zhang; Yuan Long; Yu Xu; Man Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-21       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.